JPH0658881A - Method, reagent, and device for judging absolute configuration of optical active compound - Google Patents

Method, reagent, and device for judging absolute configuration of optical active compound

Info

Publication number
JPH0658881A
JPH0658881A JP18005992A JP18005992A JPH0658881A JP H0658881 A JPH0658881 A JP H0658881A JP 18005992 A JP18005992 A JP 18005992A JP 18005992 A JP18005992 A JP 18005992A JP H0658881 A JPH0658881 A JP H0658881A
Authority
JP
Japan
Prior art keywords
compound
optically active
chemical formula
nematic phase
active compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP18005992A
Other languages
Japanese (ja)
Inventor
Tetsuya Ikemoto
哲哉 池本
Yoshitaka Kageyama
義隆 景山
Kenji Mori
謙治 森
Kazuhiro Mihashi
一宏 三橋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Rayon Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Rayon Co Ltd filed Critical Mitsubishi Rayon Co Ltd
Priority to JP18005992A priority Critical patent/JPH0658881A/en
Publication of JPH0658881A publication Critical patent/JPH0658881A/en
Pending legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)

Abstract

(57)【要約】 (修正有) 【構成】 化1で示される化合物を、被検査対象光学活
性化合物と化学結合して得られる化合物のカイラルネマ
チック相のらせんの向き、もしくは化1で示される化合
物と被検査対象光学活性化合物とを化学結合して得られ
る化合物を、ネマチック相を有する液晶化合物に添加し
た組成物のカイラルネマチック相のらせんの向きから判
断して被検査対象光学活性化合物の絶対配置を判定す
る。 (但し、式中n,p,qは各々独立に0または1で、R
は炭素数1〜18のアルキル基を示し、n=0のときX
は水素原子、ハロゲン原子、シアノ基、ニトロ基、ヒ
ドロキシ基、又はトリフルオロメチル基のいずれか1つ
であり、n=1のときXは単結合。 【効果】 被検査対象光学活性化合物が100μg程度
の少量で十分測定でき、また化1との結合をエステル結
合にすれば、後に加水分解によって回収も可能である。
(57) [Summary] (Correction) [Structure] The helical orientation of the chiral nematic phase of the compound obtained by chemically bonding the compound represented by Chemical formula 1 to the optically active compound to be tested, or represented by Chemical formula 1 The compound obtained by chemically bonding the compound and the optically active compound to be inspected is judged from the direction of the helix of the chiral nematic phase of the composition added to the liquid crystal compound having a nematic phase, and the absolute value of the optically active compound to be inspected is judged. Determine the placement. (However, in the formula, n, p, and q are independently 0 or 1, and R
Represents an alkyl group having 1 to 18 carbon atoms, and when n = 0, X
1 is any one of a hydrogen atom, a halogen atom, a cyano group, a nitro group, a hydroxy group, or a trifluoromethyl group, and when n = 1, X 1 is a single bond. [Effect] The amount of the optically active compound to be inspected can be sufficiently measured even in a small amount of about 100 μg, and if the bond with Chemical formula 1 is changed to an ester bond, it can be recovered later by hydrolysis.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、医薬、農薬、機能性材
料などに使われる光学活性化合物の絶対配置判定法、絶
対配置判定用試薬、及び絶対配置判定装置に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for determining an absolute configuration of an optically active compound used in medicines, agricultural chemicals, functional materials, etc., an absolute configuration determination reagent, and an absolute configuration determination device.

【0002】[0002]

【従来技術】光学活性化合物の絶対配置測定法として
は、励起子カイラリティー法(原田宣之、中西香爾、
「円二色性スペクトル−有機立体化学への応用」、東京
化学同人(1982))、MTPAエステル化法(J.
A.Dale,H.S.Mosher,J.Am.Ch
em.Soc.,95,512(1973))などがあ
げられる。
2. Description of the Related Art The exciton chirality method (Nobuyuki Harada, Kaji Nakanishi,
"Circular dichroism spectrum-application to organic stereochemistry", Tokyo Kagaku Dojin (1982), MTPA esterification method (J.
A. Dale, H.A. S. Mosher, J .; Am. Ch
em. Soc. , 95 , 512 (1973)) and the like.

【0003】しかし、励起子カイラリティー法は、ジオ
ールの場合のみの絶対配置測定法であり、MTPAエス
テル化法は2級アルコール、もしくはヒドロキシル基と
不斉炭素の間のメチレンがせいぜい2つまでの1級アル
コールの絶対配置を予測する方法であった。
However, the exciton chirality method is an absolute configuration measurement method only for diols, and the MTPA esterification method is a secondary alcohol, or at most two methylenes between a hydroxyl group and an asymmetric carbon. It was a method of predicting the absolute configuration of primary alcohols.

【0004】液晶を利用して絶対配置を予測する試み
は、G.Gottarelliら(Tetrahedr
on Lett.1975,1981, Tetrah
edron 37(1981)395)によってなされ
ているが、光学活性化合物を直接ネマチック相を有する
化合物に添加し、生じたカイラルネマチック相のらせん
の向きを測定しているため、例外が多く生じ、充分な予
測法とはなりえなかった。そこで、不斉炭素が官能基か
ら離れていても例外少なく絶対配置を予測できる方法が
望まれていた。
An attempt to predict the absolute configuration using liquid crystals is described in G. Gottarelli et al. (Tetrahedr
on Lett. 1975, 1981, Tetrah
edron 37 (1981) 395), an optically active compound is directly added to a compound having a nematic phase and the direction of the helix of the resulting chiral nematic phase is measured. It could not be a prediction method. Therefore, there has been a demand for a method capable of predicting the absolute configuration with few exceptions even if the asymmetric carbon is separated from the functional group.

【0005】[0005]

【発明が解決しようとする課題】本発明の目的は、被検
査対象光学活性化合物を、液晶性基と化学結合させるこ
とによって光学活性基の配列を制御し、精度よく光学活
性化合物の絶対配置を判定する方法、絶対配置判定用試
薬、及び絶対配置判定装置を提供することにある。
SUMMARY OF THE INVENTION An object of the present invention is to control the arrangement of optically active groups by chemically bonding an optically active compound to be inspected with a liquid crystalline group, and to precisely determine the absolute configuration of the optically active compound. An object is to provide a determination method, an absolute configuration determination reagent, and an absolute configuration determination device.

【0006】[0006]

【課題を解決するための手段】本発明者らは鋭意検討を
重ねた結果、被検査対象光学活性化合物を、液晶性基と
化学結合させることによって光学活性基の配列を制御す
れば、この目的達成に有効であることを見いだし、この
発明を完成するにいたった。
Means for Solving the Problems As a result of intensive investigations by the present inventors, if the optically active compound to be inspected is chemically bonded to a liquid crystalline group to control the arrangement of the optically active groups, this object can be obtained. It was found to be effective in achieving this, and the present invention was completed.

【0007】すなわち、本発明の光学活性化合物の絶対
配置判定法、絶対配置判定用試薬、及び前記絶対配置判
定装置は、 化1で示された化合物と被検査対象光学活性化合物
とを化学結合して得られる化合物のカイラルネマチック
相のらせんの向き、もしくは化1で示される化合物と被
検査対象光学活性化合物とを化学結合して得られる化合
物をネマチック相を有する液晶化合物に添加した組成物
のカイラルネマチック相のらせんの向きから判断して被
検査対象光学活性化合物の絶対配置を判定する方法、 前記絶対配置判定法を利用する目的で用いられる化
1で示される絶対配置判定用試薬、 前記絶対配置判定法を利用した装置、を特徴とする
ものである。
That is, the absolute configuration determination method for an optically active compound, the absolute configuration determination reagent, and the absolute configuration determination device of the present invention chemically bond the compound shown in Chemical formula 1 to the test optically active compound. Direction of the helix of the chiral nematic phase of the obtained compound, or the chiral of the composition obtained by adding the compound obtained by chemically bonding the compound represented by Chemical formula 1 and the optically active compound to be inspected to the liquid crystal compound having the nematic phase A method for judging the absolute configuration of an optically active compound to be inspected by judging from the direction of the helix of a nematic phase; an absolute configuration determination reagent shown in Chemical formula 1 used for the purpose of utilizing the absolute configuration determination method; It is characterized by an apparatus using a judgment method.

【化1】 (但し、式中n,p,qは各々独立に0または1で、R
は炭素数1〜18のアルキル基を示し、n=0のときX
1は水素原子、ハロゲン原子、シアノ基、ニトロ基、ヒ
ドロキシ基、又はトリフルオロメチル基のいずれか1つ
であり、n=1のときX1は単結合、
[Chemical 1] (However, in the formula, n, p, and q are independently 0 or 1, and R
Represents an alkyl group having 1 to 18 carbon atoms, and when n = 0, X
1 is any one of a hydrogen atom, a halogen atom, a cyano group, a nitro group, a hydroxy group, or a trifluoromethyl group, and when n = 1, X 1 is a single bond,

【化2】 のいずれか1つであり、ZA,ZB,ZCはそれぞれ水素
原子、ハロゲン原子、シアノ基、ニトロ基、メチル基、
メトキシ基、又はトリフルオロメチル基のいずれかであ
る。)
[Chemical 2] Z A , Z B and Z C are each a hydrogen atom, a halogen atom, a cyano group, a nitro group, a methyl group,
It is either a methoxy group or a trifluoromethyl group. )

【0008】[0008]

【作用】まず、絶対配置判定法について説明する。本発
明の絶対配置判定法の特徴は、被検査対象光学活性化合
物を液晶性基と化学結合させることにより液晶性を発現
させ、また仮にそのものが液晶性を示さなくとも、化1
で示すような化合物と化学結合することにより十分直線
性が保たれ、そのものをネマチック相を有する液晶化合
物に添加することにより、液晶状態が実現できるため、
光学活性基の配列を制御できるということにある。
First, the absolute placement determination method will be described. A feature of the absolute configuration determination method of the present invention is that the optically active compound to be inspected exhibits a liquid crystallinity by chemically bonding with a liquid crystalline group, and even if the liquid crystallinity itself does not show a liquid crystallinity,
Since sufficient linearity is maintained by chemically bonding with a compound as shown in, and by adding itself to a liquid crystal compound having a nematic phase, a liquid crystal state can be realized,
The point is that the arrangement of optically active groups can be controlled.

【0009】つまりカイラルネマチック相のらせんは、
光学活性基の絶対配置によってその立体的相互作用によ
り、ねじれる向きが決定される。
That is, the spiral of the chiral nematic phase is
The steric interaction of the absolute configuration of the optically active group determines the twisting direction.

【0010】不斉炭素が1つの場合は、絶対配置の逆の
ものは必ずらせんの向きも逆になる。このねじれの向き
がRとSのどちらの不斉に対応するかは、多数のサンプ
ルの分子構造とねじれの向きを系統的に調べることによ
り、経験的にわかると考えられる。
In the case of one asymmetric carbon, the opposite of the absolute configuration always causes the opposite direction of the helix. It is considered empirically ascertaining whether the twist direction corresponds to R or S asymmetry by systematically examining the molecular structures and twist directions of many samples.

【0011】その中で特に光学活性化合物が直鎖状のも
のは、Gray and McDonnell則(Mo
l.Cryst.Liq.Cryst.Lett.,3
4,211(1977))によって、「経験的にコア部
から何炭素離れて不斉があるかによって、不斉の絶対配
置とカイラルネマチック相のらせんの向きが一意的に決
まるのではないか」と考えられ、実施例に示した実験を
行った。その結果、全て官能基から奇数番目の不斉がS
である場合、あるいは官能基から偶数番目の不斉がRで
ある場合は、カイラルネマチック相のらせんの向きはR
に対応できることがわかった。また、官能基から偶数番
目の不斉がSである場合、あるいは官能基から奇数番目
の不斉がRである場合は、カイラルネマチック相のらせ
んの向きはLに対応できることがわかった。
Among them, particularly those in which the optically active compound has a linear structure are described in the Gray and McDonnell rule (Mo
l. Cryst. Liq. Cryst. Lett. , 3
4, 211 (1977)), "Is empirically the number of carbons away from the core and the asymmetry may uniquely determine the absolute configuration of the asymmetry and the orientation of the chiral nematic phase helix?" Therefore, the experiment shown in the example was conducted. As a result, all odd-numbered asymmetries from functional groups are S
Or if the even-numbered asymmetry from the functional group is R, the direction of the helix of the chiral nematic phase is R
It turned out that it can correspond to. Further, it was found that when the even-numbered asymmetry from the functional group is S, or when the odd-numbered asymmetry from the functional group is R, the helical direction of the chiral nematic phase can correspond to L.

【0012】つまり、カイラルネマチック相のらせんの
向きと光学活性化合物の平面構造がわかれば、絶対配置
が一意的に決まることになる。このことは、実際の天然
化合物のフェロモンに対して適用した結果、全てこの規
則に当てはまっており、絶対配置未知のフェロモンにお
いても適用されることがわかる。
That is, if the direction of the helix of the chiral nematic phase and the planar structure of the optically active compound are known, the absolute configuration will be uniquely determined. As a result of being applied to the pheromone of the actual natural compound, this is all applicable to this rule, and it can be seen that it is also applied to the pheromone of which the absolute configuration is unknown.

【0013】不斉炭素2つを有する化合物については、
それぞれの不斉に対応するカイラルネマチック相のねじ
れ力の和になっており、ねじれ力はコア部に近いほど強
く、コア部に近い不斉の絶対配置でカイラルネマチック
相のらせんの向きが決定される。
For compounds having two asymmetric carbons,
It is the sum of the twisting forces of the chiral nematic phase corresponding to each asymmetry, and the twisting force is stronger near the core part, and the direction of the chiral nematic phase helix is determined by the asymmetric absolute configuration near the core part. It

【0014】また、ねじれ力を測定することにより、も
う一方の不斉に関する情報も得られることになる。
By measuring the twisting force, information on the other asymmetry can be obtained.

【0015】ここでは光学活性化合物が直鎖状の場合を
その例としてあげたが、先記したとおり、その他の光学
活性化合物も、その分子構造とらせんのねじれの向きを
系統的に調べることによって、絶対配置とらせんのねじ
れの向きとを対応させることは可能であると考えられ
る。
Here, the case where the optically active compound is linear is given as an example, but as described above, other optically active compounds can also be systematically examined for the molecular structure and the twisting direction of the helix. , It is considered possible to associate the absolute configuration with the twisting direction of the helix.

【0016】この方法の特徴は、被検査対象光学活性化
合物が100μg程度の少量で十分測定できることであ
る。天然の化合物の多くは多量に入手できない場合が多
く、少量で測定できる点は十分に意義がある。また、化
1との結合をエステル結合にすれば、後に加水分解によ
って回収も可能である。
The characteristic of this method is that the optically active compound to be inspected can be sufficiently measured even in a small amount of about 100 μg. Many of the natural compounds are not available in large quantities, and the fact that they can be measured in small quantities is sufficiently significant. Further, if the bond with Chemical formula 1 is changed to an ester bond, it can be recovered later by hydrolysis.

【0017】次に絶対配置判定用試薬について説明す
る。
Next, the absolute configuration determination reagent will be described.

【0018】本発明の目的で使用される化1で示される
化合物は、被検査対象光学活性化合物と、化学結合をさ
せた際に液晶相を発現しやすくさせるための化合物であ
る。
The compound represented by Chemical formula 1 used for the purpose of the present invention is a compound for facilitating the development of a liquid crystal phase when chemically bound to the optically active compound to be inspected.

【0019】ここで、被検査対象光学活性化合物の不斉
炭素が、官能基から5炭素以上離れている場合には、被
検査対象光学活性化合物と化学結合して得られる化合物
が、カイラルネマチック相を有する化合物を希釈しない
で使用できるためねじれ力が弱められず好ましいが、も
ちろん、被検査対象光学活性化合物の不斉炭素が官能基
から4炭素以下しか離れていない場合においても同様の
理由で、光学活性化合物と化1で示される化合物を化学
結合して得られる化合物がカイラルネマチック相を有す
るものが好ましい。
Here, when the asymmetric carbon of the optically active compound to be inspected is separated from the functional group by 5 carbons or more, the compound obtained by chemically bonding with the optically active compound to be inspected is a chiral nematic phase. Since it is possible to use without diluting the compound having the above, the twisting power is not weakened, which is preferable, but of course, even when the asymmetric carbon of the optically active compound to be inspected is separated from the functional group by 4 carbons or less, The compound obtained by chemically bonding the optically active compound and the compound represented by Chemical formula 1 preferably has a chiral nematic phase.

【0020】このように、化1で示される化合物の中
で、様々な被検査対象光学活性化合物と化学結合させた
際に、カイラルネマチック相を示すものが好ましく使用
できる。特に好ましい例として、化3で示した化合物を
挙げることができる。
As described above, among the compounds represented by Chemical formula 1, compounds which exhibit a chiral nematic phase when chemically bonded to various optically active compounds to be tested can be preferably used. As a particularly preferable example, the compound shown in Chemical formula 3 can be mentioned.

【化3】 [Chemical 3]

【0021】また、被検査対象光学活性化合物の不斉炭
素が、官能基から4炭素以下しか離れていない場合に
は、化1で示される化合物と、被検査対象光学活性化合
物とを化学結合して得られる化合物自身は、必ずしもカ
イラルネマチック相を有する必要はない。
When the asymmetric carbon of the optically active compound to be inspected is separated from the functional group by 4 carbon atoms or less, the compound represented by Chemical formula 1 is chemically bonded to the optically active compound to be inspected. The obtained compound itself does not necessarily have a chiral nematic phase.

【0022】その際はネマチック相を有する液晶化合物
に、化1で示される化合物と、被検査対象光学活性化合
物とを化合結合して得られる化合物を添加して、誘起さ
れたカイラルネマチック相のらせんの向きを測定すれば
よい。但し、その際の前記化合物の添加量は、多量に添
加するとらせんの向きが逆転することがあるので、好ま
しくは0.1〜20mol%がよい。
In this case, a compound obtained by compounding the compound represented by Chemical formula 1 with the optically active compound to be inspected is added to the liquid crystal compound having a nematic phase, and the spiral of the induced chiral nematic phase is added. The direction of should be measured. However, the addition amount of the compound at that time is preferably 0.1 to 20 mol% because the helical direction may be reversed when added in a large amount.

【0023】被検査対象光学活性化合物の量が少ない場
合などは、上記の方法の方が優れている。
When the amount of the optically active compound to be inspected is small, the above method is superior.

【0024】被検査対象光学活性化合物と化学結合させ
た際に液晶相を発現しやすくさせるため、つまり光学活
性基の配列を制御しやすくさせるための化合物が化1で
示した化合物であるが、このような目的で使用される代
表的な化合物として、化1で示される化合物の中で、特
に好ましくは、化4で示した化合物を挙げることができ
る。
The compound shown in Chemical formula 1 is a compound for facilitating the expression of a liquid crystal phase when chemically bonded to the optically active compound to be inspected, that is, for facilitating the control of the arrangement of the optically active groups. As a typical compound used for such a purpose, among the compounds represented by Chemical formula 1, particularly preferably, the compound represented by Chemical formula 4 can be mentioned.

【化4】 [Chemical 4]

【0025】また、不斉炭素が官能基から5炭素以上離
れている被検査対象光学活性体においても、このネマチ
ック相を有する液晶に添加させる方法は特に光学活性体
自身の量が少ないときなどは感度が若干悪くなるものの
良好に使用できる。
Further, even in the optically active substance to be inspected in which the asymmetric carbon is separated from the functional group by 5 or more carbon atoms, the method of adding to the liquid crystal having the nematic phase is particularly effective when the amount of the optically active substance itself is small. It can be used satisfactorily although the sensitivity is slightly lowered.

【0026】絶対配置判定装置については、以下に説明
する。
The absolute placement determining device will be described below.

【0027】カイラルネマチック相のらせんの向きの測
定は、コンタクトメソッド(J.Billard,C.
R.Acad.Sci.,Paris,274B,33
3(1972))を用い測定する方法が簡便であり、そ
の原理を使った測定セルを図1に示す。
The spiral orientation of the chiral nematic phase can be measured by the contact method (J. Billard, C. et al.
R. Acad. Sci. , Paris, 274B , 33
3 (1972)) is simple and the measurement cell using the principle is shown in FIG.

【0028】本願発明の絶対配置測定装置とは、前記測
定セルを温度コントローラーのついた加熱器上にのせ、
測定セルの一方の注入口からカイラルネマチック相のら
せんの向きが既知の液晶化合物を毛細管現象で注入さ
せ、もう一方の注入口から被検査対象光学活性化合物と
化1で示される化合物を化学結合させて得られる化合
物、又はその化合物をネマチック相を有する液晶性化合
物に添加して得られる組成物を注入させ、接触領域を測
定セルの上下にそれぞれ直交させた偏光板をもった顕微
鏡で観察し、測定セルの向きを回転することによりネマ
チック相の黒い領域が観察されたときに被検査対象側の
化合物または組成物のらせんの向きが既知の液晶化合物
のらせんの向きと反対であると判定し、その判定結果か
ら被検査対象光学活性化合物の絶対配置を判定する装置
を示す。
The absolute configuration measuring device of the present invention means that the measuring cell is placed on a heater equipped with a temperature controller,
A liquid crystal compound whose chiral nematic phase helix direction is known is injected from one inlet of the measurement cell by capillarity, and the optically active compound to be inspected and the compound shown in Chemical formula 1 are chemically bonded from the other inlet. The resulting compound, or a composition obtained by adding the compound to a liquid crystalline compound having a nematic phase is injected, and observed with a microscope having a polarizing plate in which the contact regions are orthogonal to the upper and lower sides of the measurement cell, By rotating the direction of the measurement cell, when the black region of the nematic phase is observed, it is determined that the spiral direction of the compound or composition on the tested side is opposite to the spiral direction of the known liquid crystal compound, An apparatus for determining the absolute configuration of the optically active compound to be inspected from the determination result is shown.

【0029】その他、カイラルネマチック相のらせんの
向きの測定には、施光分散、円偏光二色性のコットン効
果の符号から測定する方法(F.D.Saeva,et
al,J.Am.Chem.Soc.,93,5928
(1971))や、ベレック式補償板を光学系に入れる
ことにより液晶セルを通った光を直線偏光とし、その偏
光方向を測定することにより測定する方法、(小沢口、
和田、応用物理,,771(1976))、さらに長
いらせんピッチの測定法としては、一方のガラスを同心
円上にラビングし、一方のガラスを平行にラビングした
セル中に液晶を注入し、生じたディスクリネーションの
方向かららせんの向きを測定する方法(内田ら、電子通
信学会論文誌,62−C,629(1979))などが
あり、それぞれの原理を利用することにより、測定した
らせんの向きから被検査対象光学活性化合物の絶対配置
を判定することができる。
In addition, in order to measure the direction of the helix of the chiral nematic phase, a method of measuring from the sign of the Cotton effect of optical dispersion and circular dichroism (FD Saeva, et.
al, J .; Am. Chem. Soc. , 93 , 5928
(1971)) or a method in which the light passing through the liquid crystal cell is made into linearly polarized light by inserting a Berek compensator into the optical system, and the polarization direction is measured (Ozawaguchi,
Wada, Applied Physics, 8 , 771 (1976)), and as a method for measuring a longer helical pitch, one glass was rubbed concentrically and liquid crystal was injected into a cell in which one glass was rubbed in parallel. There is a method of measuring the direction of the helix from the direction of the disclination (Uchida et al., IEICE Transactions, 62-C , 629 (1979)), and the like. The absolute configuration of the optically active compound to be inspected can be determined from the orientation.

【0030】[0030]

【実施例】【Example】

【0031】[実施例1][Example 1]

【化5】 p−ヒドロキシ安息香酸エチル2.3g、ジイソプロピ
ルエチルアミン2.2gをジクロロメタン20mlに溶
解させ、0℃でクロロメチルメチルエーテル1.2gを
滴下した後、1時間撹拌した。反応液を炭酸水素ナトリ
ウム水溶液にあけ、エーテル抽出し、食塩水で洗浄後、
硫酸マグネシウム上で脱水し、シリカゲルカラムクロマ
トグラフィーにより精製した。
[Chemical 5] Ethyl p-hydroxybenzoate (2.3 g) and diisopropylethylamine (2.2 g) were dissolved in dichloromethane (20 ml), and chloromethyl methyl ether (1.2 g) was added dropwise at 0 ° C, followed by stirring for 1 hour. The reaction solution was poured into an aqueous solution of sodium hydrogen carbonate, extracted with ether, washed with a saline solution,
It was dried over magnesium sulfate and purified by silica gel column chromatography.

【0032】このようにして得られた4−メトキシメト
キシ安息香酸エチルを50mlのエタノールに溶解さ
せ、4N KOH溶液を30ml加え、室温で16時間
撹拌した。この溶液に1N塩酸をpH3になるまで加
え、生じた結晶を濾過し水洗して減圧下乾燥させ、4−
メトキシメトキシ安息香酸1.3gを得た。
The ethyl 4-methoxymethoxybenzoate thus obtained was dissolved in 50 ml of ethanol, 30 ml of 4N KOH solution was added, and the mixture was stirred at room temperature for 16 hours. 1N hydrochloric acid was added to this solution until the pH reached 3, and the resulting crystals were filtered, washed with water and dried under reduced pressure.
1.3 g of methoxymethoxybenzoic acid was obtained.

【0033】このもの1.17gとS.A.Hautら
の方法(J.Org.Chem.,37,1425(1
972))に従って合成した4−(4−メトキシベンゾ
イロキシ)フェノール1.73g、N,N′−ジシクロ
ヘキシルカルボジイミド1.26gをジクロロメタン3
0mlに溶解させ10分撹拌した後、N,N−ジメチル
アミノピリジン0.37gを入れ16時間撹拌した。
1.17 g of this product and S. A. The method of Haut et al. (J. Org. Chem., 37 , 1425 (1
972)) 4- (4-methoxybenzoyloxy) phenol 1.73 g, N, N'-dicyclohexylcarbodiimide 1.26 g, and dichloromethane 3
After dissolving in 0 ml and stirring for 10 minutes, 0.37 g of N, N-dimethylaminopyridine was added and stirred for 16 hours.

【0034】溶媒を留去後、シリカゲルカラムクロマト
グラフィーにより精製し、エステル体を得て、このもの
0.82gをテトラヒドロフラン50mlに溶解させ、
撹拌下6N塩酸を30ml加え、2昼夜撹拌した。反応
液を水400mlにあけ、酢酸エチルで抽出、炭酸水素
ナトリウム水溶液、食塩水で洗浄後、硫酸マグネシウム
上で脱水、溶媒を留去した残渣をジクロロメタンでよく
洗浄した後乾燥させ、目的物化5を0.59g得た。
After the solvent was distilled off, the product was purified by silica gel column chromatography to obtain an ester product, 0.82 g of this product was dissolved in 50 ml of tetrahydrofuran,
30 ml of 6N hydrochloric acid was added with stirring, and the mixture was stirred for 2 days and nights. The reaction solution was poured into 400 ml of water, extracted with ethyl acetate, washed with an aqueous solution of sodium hydrogencarbonate and brine, dehydrated over magnesium sulfate, the solvent was distilled off, and the residue was thoroughly washed with dichloromethane and dried to obtain target compound 5. Obtained 0.59 g.

【0035】[実施例2][Embodiment 2]

【化6】 S.Krishnaswamyらの方法(Mol.Cr
yst.Liq.Cryst.,38,353(197
7))に従って合成した化6を1当量に対し、市販され
ている化7を1当量、N,N′−ジシクロヘキシルカル
ボジイミドを1当量、N,N−ジメチルアミノピリジン
0.3当量をジクロロメタン10当量中で室温下16時
間反応させ、溶媒を留去し、シリカゲルカラムクロマト
グラフィーによって精製することにより相当するエステ
ル体を得た。
[Chemical 6] S. The method of Krishnaswamy et al. (Mol. Cr
yst. Liq. Cryst. , 38 , 353 (197)
7)) to 1 equivalent of commercially available Chemical 7, 1 equivalent of N, N′-dicyclohexylcarbodiimide, 0.3 equivalent of N, N-dimethylaminopyridine, and 10 equivalents of dichloromethane. The reaction was carried out at room temperature for 16 hours, the solvent was distilled off, and the product was purified by silica gel column chromatography to obtain the corresponding ester form.

【0036】化8〜化14についても同様にして相当す
るエステル体を得た。
Corresponding ester compounds were obtained in the same manner as in Chemical formulas 8 to 14.

【化7】 [Chemical 7]

【化8】 [Chemical 8]

【化9】 [Chemical 9]

【化10】 [Chemical 10]

【化11】 [Chemical 11]

【化12】 [Chemical 12]

【化13】 [Chemical 13]

【化14】 [Chemical 14]

【化15】 [Chemical 15]

【0037】Zaschkeらの方法(Z.Chem.
7,293(1977))に従って合成した化15中に
エステル体を10wt%ドープすることによってカイラ
ルネマチック相を誘起し50℃においてらせんの向きを
測定した。
The method of Zaschke et al. (Z. Chem.
No. 7,293 (1977)), a chiral nematic phase was induced by doping 10 wt% of the ester compound into the compound 15, and the direction of the helix was measured at 50 ° C.

【0038】その結果、化7,化9,化10,化11に
対応するエステルをドープした組成物のカイラルネマチ
ック相のらせんの向きはLであり、化8,化12,化1
3,化14に対応するエステルをドープした組成物のカ
イラルネマチック相のらせんの向きはRであった。
As a result, the helical direction of the chiral nematic phase of the ester-doped composition corresponding to Chemical formula 7, Chemical formula 9, Chemical formula 10, and Chemical formula 11 is L, and Chemical formula 8, Chemical formula 12, Chemical formula 1
3, the helical direction of the chiral nematic phase of the composition doped with the ester corresponding to Chemical formula 14 was R.

【0039】すなわち、不斉炭素の絶対配置がS配置の
場合は、ヒドロキシル基から、不斉炭素までの炭素数が
奇数番目のときはカイラルネマチック相のらせんの向き
がR、偶数番目のときはLに対応している。
That is, when the absolute configuration of the asymmetric carbon is the S configuration, when the number of carbon atoms from the hydroxyl group to the asymmetric carbon is an odd number, the direction of the chiral nematic phase helix is R; Corresponds to L.

【0040】[実施例3]実施例1で合成した化5を1
当量に対し、化7を1当量、トリフェニルフォスフィン
を1当量、アゾジカルボン酸ジエチルを1当量を無水ベ
ンゼン10当量中で室温下16時間反応させ、溶媒を留
去し、シリカゲルカラムクロマトグラフィーによって精
製することにより相当するエーテル体を得た。化8〜化
14についても同様にして相当するエーテル体を得た。
[Embodiment 3] [Formula 5] synthesized in Embodiment 1
With respect to the equivalents, 1 equivalent of Chemical formula 7, 1 equivalent of triphenylphosphine, and 1 equivalent of diethyl azodicarboxylate were reacted in 10 equivalents of anhydrous benzene for 16 hours at room temperature, the solvent was distilled off, and silica gel column chromatography was performed. The corresponding ether form was obtained by purification. The corresponding ethers were obtained in the same manner as in Chemical formulas 8 to 14.

【0041】得られたエーテル体は全て、150℃では
カイラルネマチック相であり、そのらせんの向きを測定
したところ、化7,化9,化10,化11に対応するエ
ーテル体のカイラルネマチック相のらせんの向きはRで
あり、化8,化12,化13,化14に対応するエーテ
ル体のカイラルネマチック相のらせんの向きはLであっ
た。
All of the obtained ethers were in a chiral nematic phase at 150 ° C. The orientation of the helix was measured to find that the chiral nematic phase of the ethers corresponding to Chemical formula 7, Chemical formula 9, Chemical formula 10 and Chemical formula 11 The direction of the helix was R, and the direction of the helix of the chiral nematic phase of the ether corresponding to Chemical formula 8, Chemical formula 12, Chemical formula 13, and Chemical formula 14 was L.

【0042】すなわち、不斉炭素の絶対配置がSの場合
は、酸素原子から不斉炭素までの炭素数が奇数番目のと
きはカイラルネマチック相のらせんの向きがL、偶数番
目のときはRに対応している。
That is, when the absolute configuration of the asymmetric carbon is S, when the number of carbon atoms from the oxygen atom to the asymmetric carbon is odd, the helical direction of the chiral nematic phase is L, and when it is even, it is R. It corresponds.

【0043】[実施例4][Embodiment 4]

【化16】 森らの方法(Liebigs Ann.Chem.,
985,2083)によって合成された化16で示され
るフェロモン102mgを無水メタノール5mlと無水
塩化メチレン10mlとに溶解させ、窒素、酸素の順に
置換した容器中撹拌下−78℃でオゾンを注入した。
[Chemical 16] Mori et al.'S method (Liebigs Ann. Chem., 1
985 , 2083), 102 mg of the pheromone represented by Chemical formula 16 was dissolved in 5 ml of anhydrous methanol and 10 ml of anhydrous methylene chloride, and ozone was injected at -78 ° C under stirring in a container in which nitrogen and oxygen were replaced in this order.

【0044】反応液が紫色になったら再び酸素、窒素の
順で容器を置換し、水素化ホウ素ナトリウム14.5m
gをエタノール3mlに溶かした溶液を加え、−78℃
で1時間撹拌した。さらに水素化ホウ素ナトリウム7
4.3mgのメタノール溶液を加え、−78℃でさらに
1時間撹拌させ、後室温で2時間撹拌した。
When the reaction solution turned purple, the vessel was replaced again with oxygen and nitrogen in this order, and sodium borohydride (14.5 m) was added.
Add a solution of g in 3 ml of ethanol and add -78 ° C.
It was stirred for 1 hour. Further sodium borohydride 7
A methanol solution (4.3 mg) was added, and the mixture was further stirred at −78 ° C. for 1 hr and then at room temperature for 2 hr.

【0045】反応液を飽和食塩水にあけ、塩化メチレン
で抽出、食塩水で洗浄後、硫酸マグネシウムで乾燥し、
溶媒を留去し、シリカゲルカラムクロマトグラフィーに
より精製し、化17で示されるアルコール78mgを得
た。〔α〕D 18.5=−1.6(C=0.84,Et
2O)
The reaction solution was poured into saturated saline solution, extracted with methylene chloride, washed with saline solution, and dried with magnesium sulfate.
The solvent was distilled off and the residue was purified by silica gel column chromatography to obtain 78 mg of the alcohol shown in Chemical formula 17. [Α] D 18.5 = -1.6 (C = 0.84, Et
2 O)

【化17】 [Chemical 17]

【0046】[実施例5][Embodiment 5]

【化18】 森らの方法(Tetrahedron,38,2291
(1982))によって合成された化18で示されるフ
ェロモン7.2mgをエタノール1mlに溶解させ、酸
化白金を触媒とし、水素雰囲気下で室温で3時間撹拌し
た。溶媒をろ過した後、留去し、化19で示されるアル
コールを定量的に得た。
[Chemical 18] Mori et al.'S method (Tetrahedron, 38 , 2291)
(1982)), 7.2 mg of the pheromone represented by Chemical formula 18 was dissolved in 1 ml of ethanol, and the mixture was stirred under hydrogen atmosphere at room temperature for 3 hours using platinum oxide as a catalyst. After filtering the solvent, the solvent was distilled off to quantitatively obtain the alcohol represented by Chemical formula 19.

【化19】 [Chemical 19]

【0047】[実施例6][Embodiment 6]

【化20】 千田らの方法(Agric.Biol.Chem.,
,795(1983))によって合成された化20で
示されるフェロモン86.7mgを1,4−ジオキサン
6mlと水1.8mlに溶解させ、8℃に冷却した。こ
れとは別に水酸化ナトリウム231mgを水2mlに溶
かした溶液を−5℃で臭素236mgを滴下した後、
1,4−ジオキサン1.3mlを加え、このものを先に
調製したフェロモンの溶液に10℃以下になるように滴
下し、3時間撹拌した。
[Chemical 20] Method of Senda et al. (Agric. Biol. Chem., 4
8 , 795 (1983)) was dissolved in 6 ml of 1,4-dioxane and 1.8 ml of water, and cooled to 8 ° C. Separately, a solution of 231 mg of sodium hydroxide in 2 ml of water was added dropwise at -5 ° C with 236 mg of bromine.
1.3 ml of 1,4-dioxane was added, and this was added dropwise to the previously prepared pheromone solution at 10 ° C. or lower, followed by stirring for 3 hours.

【0048】反応液に、亜硫酸ナトリウム55mgを溶
かした水0.6mlを加え、15分間加熱還流した。濃
塩酸を加え、酢酸エチルで抽出、食塩水で洗浄後、溶媒
を留去した。
0.6 ml of water in which 55 mg of sodium sulfite was dissolved was added to the reaction solution, and the mixture was heated under reflux for 15 minutes. Concentrated hydrochloric acid was added, the mixture was extracted with ethyl acetate, washed with brine, and the solvent was evaporated.

【0049】残渣を無水テトラヒドロフラン0.5ml
に溶解させ、リチウムアルミニウムハイドライド76m
gを無水エーテル1.5mlに懸濁させた溶液中に滴下
し、ついで30分ゆるやかに還流させた。氷浴中で10
%炭酸水素ナトリウム水溶液0.5mlと20%水酸化
ナトリウム水溶液1mlを加え、エーテル抽出、食塩水
洗浄、溶媒を留去してシリカゲルカラムクロマトグラフ
ィーによって精製することにより、化21で示されるア
ルコール78mgを得た。〔α〕D 21.5=−1.54
(C=0.88,CHCl3
0.5 ml of anhydrous tetrahydrofuran was added to the residue.
Lithium aluminum hydride 76m
g was added dropwise to a solution suspended in 1.5 ml of anhydrous ether and then gently refluxed for 30 minutes. 10 in an ice bath
% Aqueous sodium hydrogencarbonate solution 0.5 ml and 20% aqueous sodium hydroxide solution 1 ml, ether extraction, washing with brine, evaporation of the solvent and purification by silica gel column chromatography gave 78 mg of the alcohol represented by Chemical formula 21. Obtained. [Α] D 21.5 = -1.54
(C = 0.88, CHCl 3 )

【化21】 [Chemical 21]

【0050】[実施例7]実施例4〜6で得られたフェ
ロモンを実施例3と同様にエーテル体とし、そのカイラ
ルネマチック相のらせんの向きを150℃で測定したと
ころ、すべてRであり、天然のフェロモンに対してらせ
んの向きと、酸素原子からの炭素数が分かれば、実施例
3で得られた結果と同様絶対配置が一意的に決まること
を示唆している。
[Example 7] The pheromones obtained in Examples 4 to 6 were converted into ethers in the same manner as in Example 3, and the helical orientation of the chiral nematic phase was measured at 150 ° C. It is suggested that the absolute configuration is uniquely determined by knowing the orientation of the helix with respect to the natural pheromone and the number of carbon atoms from the oxygen atom, similar to the result obtained in Example 3.

【0051】[実施例8][Embodiment 8]

【化22】 [Chemical formula 22]

【化23】 森らの方法(Libigs Ann.Chem.,19
88,717)によって合成された化22、化23で示
されるフェロモンを、実施例6と同様の方法でハロホル
ム反応させた後、リチウムアルミニウムハイドライドで
還元し対応する化24、化25で示されるアルコールを
得た。化24〔α〕D 18.5=−6.2(C=0.34,
Et2O)、化25〔α〕D 18.5=0.0(C=0.4
2,Et2O)
[Chemical formula 23] Mori et al.'S method (Libigs Ann. Chem., 19
88 , 717), the pheromones represented by Chemical formulas 22 and 23 are subjected to haloform reaction in the same manner as in Example 6, and then reduced with lithium aluminum hydride to give the corresponding alcohols represented by Chemical formulas 24 and 25. Got 24 [α] D 18.5 = -6.2 (C = 0.34,
Et 2 O), Chemical formula 25 [α] D 18.5 = 0.0 (C = 0.4
2, Et 2 O)

【0052】[0052]

【化24】 [Chemical formula 24]

【化25】 [Chemical 25]

【0053】[実施例9]実施例8で得られたフェロモ
ンを実施例3と同様にエーテル体とし、そのカイラルネ
マチック相のらせんの向きを150℃で測定したとこ
ろ、どちらもLであり、実施例3で得られた法則は酸素
原子に近い方の不斉に適応されていることがわかる。ま
た、エーテル体を10wt%、化15で示される化合物
に添加して、そのカイラルネマチック相のらせんピッチ
(P)を50℃でそれぞれCano−Wedge法(B
ull.Soc.Fr.Mineral,91,20
(1968))で測定すると、化24が4.6μm、化
25が3.2μmであった。
[Example 9] The pheromone obtained in Example 8 was converted to an ether form in the same manner as in Example 3, and the helical orientation of the chiral nematic phase thereof was measured at 150 ° C. It can be seen that the law obtained in Example 3 is applied asymmetrically to the one closer to the oxygen atom. Further, 10 wt% of an ether compound was added to the compound represented by Chemical formula 15, and the helical pitch (P) of the chiral nematic phase was measured at 50 ° C. by the Cano-Wedge method (B).
all. Soc. Fr. Mineral, 91 , 20
(1968)), the chemical formula 24 was 4.6 μm and the chemical formula 25 was 3.2 μm.

【0054】これをねじれ力(β)という観点から見る
と(β=1/ρ×1/濃度(mol%))、化24のβ
は3.4μm-1・mol-1、化25のβは5.0μm-1
・mol-1であって実施例2で得られた法則が、2つの
不斉炭素のねじれ力の和として表れていることがわかる
(5位の不斉に対応するβは4.2μm-1・mol-1
11位の不斉に対応するβは0.8μm-1・mo
-1)。
From the viewpoint of the twisting force (β) (β = 1 / ρ × 1 / concentration (mol%)), β of
Is 3.4 μm −1 · mol −1 , and β in Chemical formula 25 is 5.0 μm −1
It can be seen that the law of mol −1 and obtained in Example 2 is expressed as the sum of the twisting forces of two asymmetric carbons (β corresponding to the asymmetry at the 5-position is 4.2 μm −1.・ Mol -1 ,
Β corresponding to the 11th asymmetry is 0.8 μm -1 · mo
l -1 ).

【0055】すなわち、らせんの向きとらせんピッチを
両方測定することにより、両方の不斉の絶対配置が一意
的に決まることを示唆している。
That is, it is suggested that by measuring both the direction of the helix and the pitch of the helix, the absolute configuration of both asymmetries is uniquely determined.

【発明の効果】このように、本発明の光学活性化合物の
絶対配置判定法、絶対配置判定用試薬及び絶対配置判定
装置は、被検査対象光学活性化合物が100μg程度の
少量で十分測定でき、また化1との結合をエステル結合
にすれば、後に加水分解によって回収も可能であるとい
う優れた効果がある。
INDUSTRIAL APPLICABILITY As described above, the absolute configuration determination method, the absolute configuration determination reagent, and the absolute configuration determination device of the present invention can sufficiently measure an optically active compound to be inspected in a small amount of about 100 μg. If the bond with Chemical formula 1 is changed to an ester bond, there is an excellent effect that it can be recovered by hydrolysis later.

【図面の簡単な説明】[Brief description of drawings]

【図1】 従来のコンタクトメソッドを用い測定する方
法の原理を使ったカイラルネマチック測定用セルを上か
ら見た図である。
FIG. 1 is a view of a chiral nematic measurement cell viewed from above, which uses the principle of a measurement method using a conventional contact method.

【図2】 従来のコンタクトメソッドを用い測定する方
法の原理を使ったカイラルネマチック測定用セルの断面
図である。
FIG. 2 is a cross-sectional view of a chiral nematic measuring cell using the principle of the conventional measuring method using a contact method.

【符号の説明】[Explanation of symbols]

1:スペーサー 2:ガラス 3:ポリイミド配向膜 1: Spacer 2: Glass 3: Polyimide alignment film

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 化1で示される化合物を、被検査対象光
学活性化合物と化学結合して得られる化合物のカイラル
ネマチック相のらせんの向き、もしくは化1で示される
化合物と被検査対象光学活性化合物とを化学結合して得
られる化合物を、ネマチック相を有する液晶化合物に添
加した組成物のカイラルネマチック相のらせんの向きか
ら判断して被検査対象光学活性化合物の絶対配置を判定
する方法。 【化1】 (但し、式中n,p,qは各々独立に0または1で、R
は炭素数1〜18のアルキル基を示し、n=0のときX
1は水素原子、ハロゲン原子、シアノ基、ニトロ基、ヒ
ドロキシ基、又はトリフルオロメチル基のいずれか1つ
であり、n=1のときX1は単結合、 【化2】 のいずれか1つであり、ZA,ZB,ZCはそれぞれ水素
原子、ハロゲン原子、シアノ基、ニトロ基、メチル基、
メトキシ基、又はトリフルオロメチル基のいずれかであ
る。)
1. A compound represented by the chemical formula 1 is chemically bound to an optically active compound to be inspected, and the helical orientation of a chiral nematic phase of the compound is obtained, or the compound represented by the chemical formula 1 and the optically active compound to be inspected. A method of determining the absolute configuration of an optically active compound to be inspected by determining the compound obtained by chemical bonding of and from the direction of the helix of the chiral nematic phase of the composition in which a liquid crystal compound having a nematic phase is added. [Chemical 1] (However, in the formula, n, p, and q are independently 0 or 1, and R
Represents an alkyl group having 1 to 18 carbon atoms, and when n = 0, X
1 is any one of a hydrogen atom, a halogen atom, a cyano group, a nitro group, a hydroxy group, or a trifluoromethyl group, and when n = 1, X 1 is a single bond, Z A , Z B and Z C are each a hydrogen atom, a halogen atom, a cyano group, a nitro group, a methyl group,
It is either a methoxy group or a trifluoromethyl group. )
【請求項2】 請求項1記載の化1で示される化合物で
あって、請求項1記載の絶対配置判定法を利用する目的
で用いられる絶対配置判定用試薬。
2. A compound represented by Chemical formula 1 according to claim 1, which is used for the purpose of utilizing the absolute configuration determination method according to claim 1.
【請求項3】 請求項1記載の化1で示される化合物を
被検査対象光学活性化合物と化学結合して得られる化合
物のカイラルネマチック相のらせんの向き、もしくは化
1で示される、化合物と被検査対象光学活性化合物とを
化学結合して得られる化合物を、ネマチック相を有する
液晶化合物に添加した組成物のカイラルネマチック相の
らせんの向きを検知する手段と、前記らせんの向きから
絶対配置を判定する手段とを備える絶対配置判定装置。
3. The direction of the helix of the chiral nematic phase of the compound obtained by chemically bonding the compound represented by Chemical formula 1 according to claim 1 to the optically active compound to be inspected, or the compound represented by Chemical formula 1 and the compound A compound obtained by chemically bonding to the optically active compound to be inspected is added to a liquid crystal compound having a nematic phase, a means for detecting the helical orientation of the chiral nematic phase, and the absolute configuration is determined from the orientation of the helical. Absolute position determination device comprising:
JP18005992A 1992-06-12 1992-07-07 Method, reagent, and device for judging absolute configuration of optical active compound Pending JPH0658881A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP18005992A JPH0658881A (en) 1992-06-12 1992-07-07 Method, reagent, and device for judging absolute configuration of optical active compound

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP15354492 1992-06-12
JP4-153544 1992-06-12
JP18005992A JPH0658881A (en) 1992-06-12 1992-07-07 Method, reagent, and device for judging absolute configuration of optical active compound

Publications (1)

Publication Number Publication Date
JPH0658881A true JPH0658881A (en) 1994-03-04

Family

ID=26482134

Family Applications (1)

Application Number Title Priority Date Filing Date
JP18005992A Pending JPH0658881A (en) 1992-06-12 1992-07-07 Method, reagent, and device for judging absolute configuration of optical active compound

Country Status (1)

Country Link
JP (1) JPH0658881A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08157420A (en) * 1994-12-01 1996-06-18 Consortium Elektrochem Ind Gmbh Production of 4-hydroxyphenyl benzoate derivative
WO2004070364A1 (en) * 2003-02-06 2004-08-19 Japan Science And Technology Agency Method for the determination of absolute configuration of chiral compounds
US7462427B2 (en) 2001-09-14 2008-12-09 Qinetiq Limited Liquid crystal compounds with branched or cyclic end groups
US7834037B2 (en) 2005-11-04 2010-11-16 Amira Pharmaceuticals, Inc. 5-lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US8697730B2 (en) 2007-10-26 2014-04-15 Panmira Pharmaceuticals, Llc 5-lipoxygenase activating protein (FLAP) inhibitor
US8772495B2 (en) 2008-05-23 2014-07-08 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein inhibitor

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08157420A (en) * 1994-12-01 1996-06-18 Consortium Elektrochem Ind Gmbh Production of 4-hydroxyphenyl benzoate derivative
US7462427B2 (en) 2001-09-14 2008-12-09 Qinetiq Limited Liquid crystal compounds with branched or cyclic end groups
WO2004070364A1 (en) * 2003-02-06 2004-08-19 Japan Science And Technology Agency Method for the determination of absolute configuration of chiral compounds
US7736902B2 (en) 2003-02-06 2010-06-15 Japan Science And Technology Agency Method for determination of absolute configuration of chiral compounds
US7834037B2 (en) 2005-11-04 2010-11-16 Amira Pharmaceuticals, Inc. 5-lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US8710081B2 (en) 2005-11-04 2014-04-29 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US8841295B2 (en) 2005-11-04 2014-09-23 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US8697730B2 (en) 2007-10-26 2014-04-15 Panmira Pharmaceuticals, Llc 5-lipoxygenase activating protein (FLAP) inhibitor
US8772495B2 (en) 2008-05-23 2014-07-08 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein inhibitor

Similar Documents

Publication Publication Date Title
JPH0658881A (en) Method, reagent, and device for judging absolute configuration of optical active compound
KR100716969B1 (en) Vertically oriented liquid crystal compound and liquid crystal composition comprising the same
CN109369636A (en) A two-photon fluorescent probe for distinguishing different viscosities and its preparation method and application
EP0893429B1 (en) Ferrielectric liquid crystal compound
US20090066905A1 (en) Componds for use in liquid crystal devices
JPH0558952A (en) Fluorinated liquid crystal
CN104293356A (en) Application of a liquid crystal compound as a high birefringence liquid crystal material or in improving the birefringence of a liquid crystal host
TW201038522A (en) Liquid crystal chemical compound having difluoropropenyleneoxy bonding group
JPH0952859A (en) Naphthalene derivative and liquid crystal composition containing the derivative
US6007739A (en) Liquid crystal compound, liquid crystal composition, and liquid crystal display device using the same
JPH05331107A (en) Antiferroelectric liquid crystal compound
JPH068265B2 (en) Liquid crystalline compound
JPH05202028A (en) Optically active compound having thiophene ring
JPH0643376B2 (en) Liquid crystalline compound
EP0468882B1 (en) Liquid crystal compound
EP0994098B1 (en) Ferrielectric liquid crystal compound
CN1315801C (en) Novel LCD compound p-n-octoxy cinnamic acid -2-fluoro-4-hydroxy- benzonitrile ester and its preparation method
JP2880524B2 (en) Liquid crystal compound
CN1315796C (en) Novel LCD compound p-isoamoxy cinnamic acid -2-fluoro-4-hydroxy- benzonitrile ester and its preparation method
JPH0629203B2 (en) Liquid crystalline compound
CN1315799C (en) Novel LCD compound p-n-propoxy cinnamic acid -2-fluoro-4-hydroxy- benzonitrile ester and its preparation method
EP0974636B1 (en) Ferrielectric liquid crystal compound
CN100339361C (en) Novel liquid crystal compound-3-(4-n-dekaoxylbenzyl)acrylic acid-2-fluo-4-hydroxybenzenenitrile ester and its preparation method
CN1315798C (en) Novel LCD compound p-n-heptyloxy cinnamic acid -2-fluoro-4-hydroxy- benzonitrile ester and its preparation method
JPH0632764A (en) Optically active compound and display element